We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.82B
AUM Growth
+$180M
Cap. Flow
-$33.6M
Cap. Flow %
-1.19%
Top 10 Hldgs %
27.95%
Holding
252
New
10
Increased
83
Reduced
86
Closed
12

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.1M
2
CHTR icon
Charter Communications
CHTR
+$33.9M
3
LHX icon
L3Harris
LHX
+$20.4M
4
ABBV icon
AbbVie
ABBV
+$18.8M
5
RVTY icon
Revvity
RVTY
+$17.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.8M
2
TIF
Tiffany & Co.
TIF
+$55.9M
3
BHC icon
Bausch Health
BHC
+$29.3M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$16M
5
NBLX
Noble Midstream Partners LP
NBLX
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 19.19%
2 Healthcare 18.54%
3 Industrials 12.76%
4 Financials 12.25%
5 Consumer Discretionary 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
126
Amgen
AMGN
$198B
$2.64M 0.09%
10,935
– –
BMY.RT
127
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.59M 0.09%
+860,305
New +$2.24M
ECL icon
128
Ecolab
ECL
$76.8B
$2.56M 0.09%
13,265
+740
+6% +$140K
PARA
129
DELISTED
Paramount Global Class B
PARA
$2.44M 0.09%
58,045
-43,724
-43% -$1.69M
B
130
Barrick Mining
B
$58.5B
$2.28M 0.08%
122,500
-19,000
-13% -$326K
BDX icon
131
Becton Dickinson
BDX
$43.6B
$2.22M 0.08%
8,379
– –
NTRS icon
132
Northern Trust
NTRS
$34.2B
$2.19M 0.08%
20,660
– –
MO icon
133
Altria Group
MO
$124B
$2.18M 0.08%
43,612
+223
+0.5% +$10.5K
NVS icon
134
Novartis
NVS
$293B
$2.09M 0.07%
22,052
+1,025
+5% +$92K
EMR icon
135
Emerson Electric
EMR
$78.2B
$2.02M 0.07%
26,490
+361
+1% +$26K
ALEC icon
136
Alector
ALEC
$167M
$2M 0.07%
116,250
+23,125
+25% +$393K
CNNE icon
137
Cannae Holdings
CNNE
$657M
$1.92M 0.07%
51,700
+6,000
+13% +$197K
NEM icon
138
Newmont
NEM
$95.8B
$1.85M 0.07%
42,538
+1,750
+4% +$68.4K
TRAK icon
139
ReposiTrak
TRAK
$160M
$1.74M 0.06%
343,400
-208,734
-38% -$1.07M
BABA icon
140
Alibaba
BABA
$276B
$1.71M 0.06%
8,050
+655
+9% +$123K
SCOR icon
141
Comscore
SCOR
$113M
$1.7M 0.06%
17,233
-7,336
-30% -$502K
A icon
142
Agilent Technologies
A
$37.1B
$1.64M 0.06%
19,217
-6,000
-24% -$472K
CDK
143
DELISTED
CDK Global, Inc.
CDK
$1.56M 0.06%
28,464
– –
GAM
144
General American Investors Company
GAM
$1.54B
$1.54M 0.05%
40,808
+2,549
+7% +$93.9K
NEE icon
145
NextEra Energy
NEE
$185B
$1.52M 0.05%
25,188
– –
PNC icon
146
PNC Financial Services
PNC
$101B
$1.47M 0.05%
9,196
– –
WFC icon
147
Wells Fargo
WFC
$265B
$1.47M 0.05%
27,281
+315
+1% +$16.5K
VZ icon
148
Verizon
VZ
$182B
$1.45M 0.05%
23,656
+1,368
+6% +$82.5K
PSX icon
149
Phillips 66
PSX
$82.9B
$1.44M 0.05%
12,964
– –
GILD icon
150
Gilead Sciences
GILD
$167B
$1.33M 0.05%
20,460
+435
+2% +$28.3K
4 5
6
7 8

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Cannell & Co held 252 positions worth $2.82B, up 6.8% from $2.64B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2019 filing shows 10 new, 83 increased, 86 reduced and 12 closed positions. Its largest new stake was Charter Communications: 73,678 shares worth $36.1M. The largest sale was Celgene Corp, an estimated $60.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Co's largest Q4 2019 buy was Charter Communications: 73,678 shares worth $36.1M.
  • Cannell & Co added most to Bristol-Myers Squibb in Q4 2019, an estimated $36.1M increase.
  • Cannell & Co's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $55.9M.
  • Cannell & Co fully exited Celgene Corp in Q4 2019, selling an estimated $60.8M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.82B portfolio in Q4 2019.
  • Cannell & Co opened 10 new positions and closed 12 in Q4 2019.
  • Cannell & Co's portfolio value rose 6.8% quarter-over-quarter to $2.82B.

Based on Cannell & Co's 13F filing for Q4 2019, filed 10 Feb 2020.